INNOVENTRIC: Funding, Investors & Team (Sep 2026)
Innoventric is a Structural Heart medical device company, mainly engaged in the development of percutaneous solutions for Tricuspid Regurgitation and right heart disease. Innoventric, a start-up company from Ness-Ziona, Israel, develops the unique Trillium™ technology for the treatment of Tricuspid Valve Regurgitation. The company was founded in 2017, and has rapidly progressed. Innoventric has performed over 10 implantations of the promising Trillium™ technology as part of its European first in human clinical trial. The company holds a broad patent portfolio for the Trillium™ and additional Tricuspid technologies.
INNOVENTRIC has raised $14.0M across 1 funding round on record, the most recent a Series A of $14.0M announced in Nov 2021.
That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
INNOVENTRIC Company Profile and Key Stats
Latest funding round on record: Nov 2021.
INNOVENTRIC Funding Rounds
INNOVENTRIC Founders and Leadership Team
No contact details are on record for this team yet.
INNOVENTRIC Funding Compared to Other Health Care Startups
INNOVENTRIC's latest round of $14.0M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like INNOVENTRIC in Health Care and Ness Ziona
Companies Similar to INNOVENTRIC
QuantHealth is an organization that produces software using artificial intelligence technology for drug…
Inspira Technologies is a cutting-edge medical technology company that specializes in the acute respiratory…
Alpha Tau Medical is an Israeli medical device company that focuses on research, development and…
Adenocyte is a privately held medical technology business that focuses on early diagnosis of adenocarcinoma…
Vortex Imaging develops medical imaging devices.
Urologic Health developing innovative solutions to improve bladder function diagnosis, monitoring, and…
VISIONIX develops, manufactures and distributes innovative equipment and provides a complete solution for…
Fize Medical is a health care company based in Israel.
Synchrony Medical is a clinical stage medical device company developing LibAirty, a next generation,…
TopGum has developed a highly scalable patent-pending delivery system with the capacity to deliver a wide…
Nanox offers the Nanox System as a preventative healthcare Medical Screening As A Service (MSaaS). Nanox…
Microbot Medical is a company that creates innovative medical devices using micro-robotic technology. They…
INNOVENTRIC Funding FAQs
What does INNOVENTRIC do?
Innoventric is a Structural Heart medical device company, mainly engaged in the development of percutaneous solutions for Tricuspid Regurgitation and right heart disease. Innoventric, a start-up company from Ness-Ziona, Israel, develops the unique Trillium™ technology for the treatment of Tricuspid Valve Regurgitation. The company was founded in 2017, and has rapidly progressed. Innoventric has performed over 10 implantations of the promising Trillium™ technology as part of its European first in human clinical trial. The company holds a broad patent portfolio for the Trillium™ and additional Tricuspid technologies.
How much funding has INNOVENTRIC raised?
INNOVENTRIC has raised $14.0M across 1 round on record. The most recent is a Series A of $14.0M announced in Nov 2021.
When did INNOVENTRIC last raise funding?
INNOVENTRIC's most recent funding round on record is a Series A of $14.0M, announced in Nov 2021.
Who is the CEO of INNOVENTRIC?
Amir Danino is listed as CEO at INNOVENTRIC.
Where is INNOVENTRIC headquartered?
INNOVENTRIC is based in Ness Ziona, Hamerkaz, Israel.
How many employees does INNOVENTRIC have?
INNOVENTRIC is in the 11-50 employee band.
How does INNOVENTRIC's funding compare to other Health Care startups?
INNOVENTRIC's latest round of $14.0M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's INNOVENTRIC Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for INNOVENTRIC is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.